Literature DB >> 1922823

Primary carnitine deficiency: heterozygote and intrafamilial phenotypic variation.

B Garavaglia1, G Uziel, F Dworzak, F Carrara, S DiDonato.   

Abstract

Two boys from different families had primary carnitine deficiency: one had cardiomyopathy and myopathy, and the other had hypoglycemia and myopathy but no cardiomyopathy. Uptake of carnitine by cultured fibroblasts was negligible in both patients. Vmax for carnitine transport was reduced to 50% of controls' value in the parents and one brother (who had hypertrophic cardiomyopathy) of the first patient. A brother of the second non-cardiopathic patient died at an early age with autopsy findings of a dilated cardiomyopathy and low cardiac carnitine. Autosomal recessive primary carnitine deficiency can express a variable phenotype in different families as well as within the same family. Heterozygotes can manifest heart involvement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922823     DOI: 10.1212/wnl.41.10.1691

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency.

Authors:  M Kilic; R K Ozgül; T Coşkun; D Yücel; M Karaca; H S Sivri; A Tokatli; M Sahin; T Karagöz; A Dursun
Journal:  JIMD Rep       Date:  2011-09-22

2.  Clinical and biochemical findings in a Spanish boy with primary carnitine deficiency.

Authors:  P Briones; B Garavaglia; A Ribes; M E Yoldi; M Rodés; C Romero; F García-Bragado
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 3.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.

Authors:  Y Wang; J Ye; V Ganapathy; N Longo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Medium-chain triglyceride loading test in carnitine-acylcarnitine translocase deficiency: insights on treatment.

Authors:  R Parini; F Invernizzi; F Menni; B Garavaglia; D Melotti; M Rimoldi; S Salera; C Tosetto; F Taroni
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

Review 6.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

7.  Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid.

Authors:  K Abrahamsson; M Mellander; B O Eriksson; E Holme; U Jodal; A Jönsson; S Lindstedt
Journal:  Br Heart J       Date:  1995-12

8.  Evidence for linkage of human primary systemic carnitine deficiency with D5S436: a novel gene locus on chromosome 5q.

Authors:  Y Shoji; A Koizumi; T Kayo; T Ohata; T Takahashi; K Harada; G Takada
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

Review 9.  Primary carnitine deficiency and cardiomyopathy.

Authors:  Lijun Fu; Meirong Huang; Shubao Chen
Journal:  Korean Circ J       Date:  2013-12       Impact factor: 3.243

10.  Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency.

Authors:  Jan Rasmussen; Allan M Lund; Lotte Risom; Flemming Wibrand; Hannes Gislason; Olav W Nielsen; Lars Køber; Morten Duno
Journal:  Mol Genet Metab Rep       Date:  2014-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.